Intravitreal Expert Group
  • Home
  • Virtual Clinics
  • Expert Views
  • How to Inject
  • Fundamentals
  • About Us
  • Live

Home / Which anti-VEGF treatment regimen?

13th Jul 2018

Which anti-VEGF treatment regimen?

News

Intravitreal anti-vascular endothelial growth factor agents, such as aflibercept, ranibizumab, and bevacizumab, have revolutionised the way neovascular retinal diseases are managed. However, there are still questions about the most effective dosing schedule for these medications to help optimise treatment effect and patient experience. Here, Sebastian Wolf highlights the key differences between the most commonly used dosing schedule.

Watch now

Categories

  • AMD
  • Articles
  • COVID-19
  • DR and DME
  • Intravitreal injections
  • Latest contents
  • Meetings and congresses
  • News
  • Ocular Trauma
  • Other pathologies
  • Research and clinical trials
  • Retinal imaging
  • ROP
  • RVO
  • Videos
IVEG_Logo
  • Home
  • Virtual Clinics
  • Expert Views
  • How to Inject
  • Fundamentals
  • About Us

Sign up to newsletter

Enter a valid email!

Check the boxes below to proceed with newsletter signup!

You are already in our database, update your data!

If you don't want to receive further communications, you can remove the subscription HERE

Designed and created by Etcetera Communication | privacy policy | cookie policy